15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 14 firms covering Nutrien Ltd, 10 rate it Buy or better, 3 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $63.00 to $82.00, so the covering firms are broadly aligned. The average target of $75.14 sits 8% above the current $69.46. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 2 to 1 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.20 next quarter toward $5.18 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS14 ratings
Moderate Buy
Strong Buy00%
Buy1071%
Hold321%
Sell17%
Strong Sell00%
Based on 14 analysts giving stock ratings to Nutrien Ltd.
As of Jul, 10 of 14 firms rate NTR a Buy (3 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
NTR EPS & revenue forecast
EPS · NEXT QUARTER
$1.20
Range $0.74 – $1.54 · 15 analysts · +24% YoY
Next period, 15 analysts expect Nutrien Ltd to earn $1.20 a share (range $0.74 – $1.54), versus $0.97 a year earlier. Full-year consensus is $5.69, growing to $5.18 the year after.
REVENUE · NEXT QUARTER
$5.9B
Range $5.7B – $6.1B · 15 analysts · +2% YoY
Revenue is expected to reach $5.9B (range $5.7B – $6.1B), +2.0% year-over-year. Full-year consensus is $27.9B, rising to $27.2B next year.
Top analysts covering Nutrien Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NTR.
#1
Jeffrey Zekauskas
JP Morgan · Rank #53
Buy
$80.00+15.2% to target
Overall win rate
54%
+ Follow
#2
Benjamin Theurer
Barclays · Rank #72
Buy
$85.00+22.4% to target
Overall win rate
47%
+ Follow
#3
Michael Sison
Wells Fargo · Rank #183
Buy
$90.00+29.6% to target
Overall win rate
45%
+ Follow
#4
Kristen Owen
Oppenheimer · Rank #288
Buy
$82.00+18.1% to target
Overall win rate
23%
+ Follow
#5
Ben Isaacson
Scotiabank
Buy
$80.00+15.2% to target
Coverage
—
+ Follow
NTR stock forecast FAQ
What is NTR's average 12-month price target?+
The 7 analysts with a live target average $75.14 for Nutrien Ltd over the next 12 months, ranging from a $82.00 high to a $63.00 low.
Is NTR stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 14 analyst ratings, 10 are Buy or Strong Buy, 3 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for NTR?+
The Street-high target is $82.00 (Oppenheimer), and the Street-low is $63.00 (Jefferies). The average of all 7 active targets is $75.14.
How many Wall Street analysts cover NTR?+
14 analysts have an active rating on Nutrien Ltd, and 7 firms carry a live 12-month price target.
Who is the most accurate analyst covering NTR?+
Among analysts who currently cover NTR, Jeffrey Zekauskas of JP Morgan has the strongest overall Quantellect track record (Rank #53). Their current call is Buy with a $80.00 target.
What is Nutrien Ltd's projected EPS for next quarter?+
The consensus estimate is $1.20 per share (range $0.74 – $1.54) across 15 analysts. Full-year EPS is projected at $5.69, rising to $5.18 the following year.
How much revenue is Nutrien Ltd expected to report next quarter?+
Consensus revenue is $5.9B (range $5.7B – $6.1B). Full-year revenue is projected at $27.9B, growing to $27.2B next year.
Have analysts been upgrading or downgrading NTR lately?+
As of Jul, 10 of 14 firms rate NTR a Buy (3 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NTR calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
